Literature DB >> 31049791

Gender and thrombolysis therapy in acute ischemic stroke patients with incidence of obesity.

Brice Blum1, Alexandria Penwell1, Leah Wormack1, Brittany Walker1, Shyyon Lari1, Thomas I Nathaniel2.   

Abstract

OBJECTIVE: To investigate clinical risk factors that were associated with gender differences in thrombolysis therapy in stroke patients with incidence of obesity.
METHOD: Retrospective data of obese acute ischemic stroke patients were extracted from a stroke registry between January 2010 and June 2016. Gender differences in exclusion from rtPA or thrombolysis therapy were determined following an adjustment for differences in demographics, clinical risk factors using multiple regression analysis. Significant interactions between variables in the regression models were determined using variance inflation factors.
RESULTS: A total of 1105 obese stroke patients were admitted, 549 were excluded from rtPA of which 51.7% were males and 48.3% were females. Among obese male stroke patients, age > 80 years (OR = 1.029, 95% CI, 1.005-1.054, P = 0.016), a history of peripheral vascular disease (OR = 3.008, 95% CI, 0.989-9.153, P = 0.052), and an elevated diastolic blood pressure (OR = 1.018, 95% CI, 1.001-1.035, P = 0.038) were associated with exclusion from rtPA therapy. In obese female stroke patients, coronary artery disease was associated with exclusion from rtPA (OR = 2.478, 95% CI, 1.270-4.836, P = 0.008) while antihypertensive therapy was associated with inclusion for rtPA (OR = 0.326, 95% CI, 0.139-0.764).
CONCLUSION: Elderly obese male stroke patients with elevated diastolic blood pressure, history of peripheral vascular disease, and obese female stroke patients with a history of coronary artery disease were more likely to be excluded from rtPA.

Entities:  

Keywords:  Activator (rtPA); Gender; Ischemic stroke; Obesity; Recombinant tissue-type plasminogen

Mesh:

Substances:

Year:  2019        PMID: 31049791     DOI: 10.1007/s10072-019-03902-7

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  37 in total

1.  Sex differences in stroke recovery and stroke-specific quality of life: results from a statewide stroke registry.

Authors:  Julia Warner Gargano; Mathew J Reeves
Journal:  Stroke       Date:  2007-08-02       Impact factor: 7.914

2.  Why are eligible thrombolysis candidates left untreated?

Authors:  Nancy K Hills; S Claiborne Johnston
Journal:  Am J Prev Med       Date:  2006-11-07       Impact factor: 5.043

3.  Evidence for age and sex differences in the secondary prevention of stroke in Scottish primary care.

Authors:  C R Simpson; C Wilson; P C Hannaford; D Williams
Journal:  Stroke       Date:  2005-07-21       Impact factor: 7.914

4.  Sex differences in stroke care and outcomes: results from the Registry of the Canadian Stroke Network.

Authors:  Moira K Kapral; Jiming Fang; Michael D Hill; Frank Silver; Janice Richards; Cheryl Jaigobin; Angela M Cheung
Journal:  Stroke       Date:  2005-02-24       Impact factor: 7.914

5.  Treatment with tissue plasminogen activator and inpatient mortality rates for patients with ischemic stroke treated in community hospitals.

Authors:  S D Reed; S C Cramer; D K Blough; K Meyer; J G Jarvik
Journal:  Stroke       Date:  2001-08       Impact factor: 7.914

6.  Cause-specific excess deaths associated with underweight, overweight, and obesity.

Authors:  Katherine M Flegal; Barry I Graubard; David F Williamson; Mitchell H Gail
Journal:  JAMA       Date:  2007-11-07       Impact factor: 56.272

7.  Sex and acute stroke presentation.

Authors:  Lise A Labiche; Wenyaw Chan; Kamaldeen R Saldin; Lewis B Morgenstern
Journal:  Ann Emerg Med       Date:  2002-11       Impact factor: 5.721

8.  Utilization of intravenous tissue plasminogen activator for acute ischemic stroke.

Authors:  Irene L Katzan; Maxim D Hammer; Eric D Hixson; Anthony J Furlan; Alex Abou-Chebl; Deborah M Nadzam
Journal:  Arch Neurol       Date:  2004-03

9.  Sex differences in acute stroke care in a statewide stroke registry.

Authors:  Julia Warner Gargano; Susan Wehner; Mathew Reeves
Journal:  Stroke       Date:  2007-11-29       Impact factor: 7.914

Review 10.  Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes.

Authors:  Mathew J Reeves; Cheryl D Bushnell; George Howard; Julia Warner Gargano; Pamela W Duncan; Gwen Lynch; Arya Khatiwoda; Lynda Lisabeth
Journal:  Lancet Neurol       Date:  2008-08-21       Impact factor: 44.182

View more
  6 in total

1.  Stroke Severity among Men and Women Acute Ischemic Stroke Patients in the Telestroke Network.

Authors:  Nicolas Poupore; Camron Edrissi; Mareshah Sowah; Madison Stanley; Jonah Joffe; Donovan Lewis; Teanda Cunningham; Carolyn Breauna Sanders; Krista Knisely; Chase Rathfoot; Thomas I Nathaniel
Journal:  Cerebrovasc Dis Extra       Date:  2022-06-08

2.  The Association Between an Antecedent of Transient Ischemic Attack Prior to Onset of Stroke and Functional Ambulatory Outcome.

Authors:  Nicolas Poupore; Dan Strat; Tristan Mackey; Thomas I Nathaniel
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

3.  In acute ischemic stroke patients with smoking incidence, are more women than men more likely to be included or excluded from thrombolysis therapy?

Authors:  Oluyemi R Rotimi; Iretioluwa F Ajani; Alexandria Penwell; Shyyon Lari; Brittany Walker; Thomas I Nathaniel
Journal:  Womens Health (Lond)       Date:  2020 Jan-Dec

4.  Comorbidities associated with different levels of total cholesterol in male and female acute ischemic stroke patients.

Authors:  Leanne Brechtel; Nicolas Poupore; Teodora Stoikov; Laurie Theriot Roley; John F Emerson; Thomas Nathaniel
Journal:  Medicine (Baltimore)       Date:  2020-12-24       Impact factor: 1.889

5.  Obstructive sleep apnea and stroke severity: Impact of clinical risk factors.

Authors:  Carolyn Breauna Sanders; Krista Knisely; Camron Edrissi; Chase Rathfoot; Nicolas Poupore; Leah Wormack; Thomas Nathaniel
Journal:  Brain Circ       Date:  2021-05-29

6.  Cholesterol reducer and thrombolytic therapy in acute ischemic stroke patients.

Authors:  Nicolas Poupore; Dan Strat; Tristan Mackey; Katherine Brown; Ashley Snell; Thomas I Nathaniel
Journal:  Lipids Health Dis       Date:  2020-05-06       Impact factor: 3.876

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.